Skip to Content

Cancer Treatment Startup Based on U Research Wins Tekne Award

picture of award

A startup company that develops next-generation cancer treatments based on University of Minnesota research has been awarded for its innovative therapies.

GeneSegues Therapeutics received the Minnesota High Tech Association’s Tekne Award Wednesday night in the category of Health Care — Small and Growing. Tekne Awards recognize innovation across Minnesota in industries ranging from advanced manufacturing, health care and agricultural technology.

GeneSegues develops microscopic capsules that serve as a vessel to transport gene therapies through the body that help stop the spread of cancer. The capsules are smaller than conventional nanoparticles, allowing them to slip past the human body’s biological barriers and attack cancerous cells more precisely, while leaving healthy cells unharmed.

The company grew out of research done by U of M post-doc Gretchen Unger, Ph.D., in the early 2000s. Unger is currently chief scientific officer with the company. The company’s CEO is Laura Brod, who is also an at-large member of the University’s Board of Regents.

Kevin Coss

Kevin Coss

Kevin is a writer and public relations associate with the Office of the Vice President for Research.

Latest Blog Posts

Schilling Alaskan Paper Birch tree with white rot

U researchers' work in understanding how different fungi rot trees will help climate modelers predict changes in terrestrial and atmospheric carbon pools.

Read More
Aerial view of farms

New research projects underway within University of Minnesota Extension aim to support the prosperity of rural areas across the state.

Read More
Overhead view of a crowd in a shopping mall

Middle- and working-class workers’ earnings in the US have been stagnating or sinking in recent decades, and researchers believe this trend may stem from the factors in play at the beginning of workers’ careers.

Read More
Scientists in a laboratory

Thirteen projects received over $2.5 million in 2017 Research Infrastructure Awards, which invest in the U's ability to conduct state-of-the-art research.

Read More